These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 6604918)

  • 21. Differential expression of tumor target binding and cytolytic activities in bone marrow culture-derived macrophages.
    Lee KC; La Posta VJ
    J Natl Cancer Inst; 1986 Dec; 77(6):1287-97. PubMed ID: 3467118
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunological activities of RU-41740, a glycoproteic extract from Klebsiella pneumoniae. II.--Activation of macrophage cytotoxicity against tumour cells and production of a cytotoxic factor.
    Vacheron F; Smets P; Nauciel C; Guenounou M
    Ann Inst Pasteur Immunol; 1987; 138(4):571-84. PubMed ID: 3118904
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interleukin 10 inhibits macrophage microbicidal activity by blocking the endogenous production of tumor necrosis factor alpha required as a costimulatory factor for interferon gamma-induced activation.
    Oswald IP; Wynn TA; Sher A; James SL
    Proc Natl Acad Sci U S A; 1992 Sep; 89(18):8676-80. PubMed ID: 1528880
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanisms of target recognition and destruction in macrophage-mediated tumor cytotoxicity.
    Adams DO; Johnson WJ; Marino PA
    Fed Proc; 1982 Apr; 41(6):2212-21. PubMed ID: 6804274
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enhancement of cytotoxicity of active macrophages by mycoplasma: role of mycoplasma-associated induction of tumor necrosis factor-alpha (TNF-alpha) in macrophages.
    Arai S; Furukawa M; Munakata T; Kuwano K; Inoue H; Miyazaki T
    Microbiol Immunol; 1990; 34(3):231-43. PubMed ID: 2352496
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of 3LL-tumor variants generated by in vitro macrophage-mediated selection.
    Remels LM; De Baetselier PC
    Int J Cancer; 1987 Mar; 39(3):343-52. PubMed ID: 3818124
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activation of macrophage tumor cytotoxicity by the synergism of two T cell-derived lymphokines: immune interferon (IFN-gamma) and macrophage cytotoxicity-inducing factor 2 (MCIF2).
    Hamann U; Krammer PH
    Eur J Immunol; 1985 Jan; 15(1):18-24. PubMed ID: 3917924
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Solid tumor-derived target cell susceptibility to macrophages and natural killer/natural cytotoxic cells in the rat.
    Zöller M; Matzku S
    Immunobiology; 1983 May; 164(5):349-60. PubMed ID: 6603412
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The human LT system. XII. Purification and functional studies of LT and "TNF-like" LT forms from a continuous human T cell line.
    Kobayashi M; Plunkett JM; Masunaka IK; Yamamoto RS; Granger GA
    J Immunol; 1986 Sep; 137(6):1885-92. PubMed ID: 2427583
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Potentiation of lymphokine-induced macrophage activation by tumor necrosis factor-alpha.
    Heidenreich S; Weyers M; Gong JH; Sprenger H; Nain M; Gemsa D
    J Immunol; 1988 Mar; 140(5):1511-8. PubMed ID: 3126228
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Studies on the mechanism of macrophage cytotoxicity.
    Zippel D
    Exp Pathol; 1985; 27(1):3-15. PubMed ID: 4040029
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Studies on lymphokines: the production of antibody to guinea pig lymphotoxin and its use to distinguish lymphotoxin from migration inhibitory factor and mitogenic factor.
    Gately MK; Gately CL; Henney CS; Mayer MM
    J Immunol; 1975 Sep; 115(3):817-26. PubMed ID: 1097529
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of human tumor necrosis factor produced by peripheral blood monocytes and its separation from lymphotoxin.
    Kelker HC; Oppenheim JD; Stone-Wolff D; Henriksen-DeStefano D; Aggarwal BB; Stevenson HC; Vilcek J
    Int J Cancer; 1985 Jul; 36(1):69-73. PubMed ID: 3874835
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased sensitivity of tumor-bearing host macrophages to interleukin-10: a counter-balancing action to macrophage-mediated suppression.
    Alleva DG; Burger CJ; Elgert KD
    Oncol Res; 1994; 6(4-5):219-28. PubMed ID: 7841545
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IFN-gamma differentially modulates the susceptibility of L1210 and P815 tumor targets for macrophage-mediated cytotoxicity. Role of macrophage-target interaction coupled to nitric oxide generation, but independent of tumor necrosis factor production.
    Leu RW; Leu NR; Shannon BJ; Fast DJ
    J Immunol; 1991 Sep; 147(6):1816-22. PubMed ID: 1909732
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Studies on the mechanism of liver injury by macrophage-mediated cytotoxicity--partial purification of cytotoxic factor detected in the culture supernatant of activated macrophages.
    Mizoguchi Y; Tsutsui H; Monna T; Yamamoto S; Morisawa S
    Gastroenterol Jpn; 1983 Feb; 18(1):41-6. PubMed ID: 6339309
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interferon-gamma synergizes with tumor necrosis factor and with interleukin 1 and requires the presence of both monokines to induce antitumor cytotoxic activity in macrophages.
    Chen L; Suzuki Y; Wheelock EF
    J Immunol; 1987 Dec; 139(12):4096-101. PubMed ID: 3121728
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Leukemic cell lysis by activated human macrophages: significance of membrane-associated tumor necrosis factor.
    Nakabo Y; Harakawa N; Yamamoto K; Okuma M; Uno K; Sasada M
    Jpn J Cancer Res; 1993 Nov; 84(11):1174-80. PubMed ID: 8276722
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antibody to recombinant murine tumor necrosis factor (TNF) neutralizes guinea pig TNF.
    Ruppel-Kerr R; Lemp JA; Karol MH
    J Immunol Methods; 1992 Oct; 154(2):179-84. PubMed ID: 1401952
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of recombinant human tumor necrosis factor on the induction of murine macrophage tumoricidal activity.
    Hori K; Ehrke MJ; Mace K; Maccubbin D; Doyle MJ; Otsuka Y; Mihich E
    Cancer Res; 1987 Jun; 47(11):2793-8. PubMed ID: 2882835
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.